Songtao Li Selected Research

IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)

1/2019	Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease.
5/2016	Salmeterol enhances the cardiac response to gene therapy in Pompe disease.
1/2013	Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
6/2011	Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
11/2010	Antibody formation and mannose-6-phosphate receptor expression impact the efficacy of muscle-specific transgene expression in murine Pompe disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Songtao Li Research Topics

Disease

19	Glycogen Storage Disease Type II (Pompe's Disease) 01/2022 - 08/2008
13	Non-alcoholic Fatty Liver Disease 06/2022 - 01/2014
9	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2022 - 11/2012
6	Inflammation (Inflammations) 08/2022 - 08/2014
6	Hepatorenal form of glycogen storage disease 12/2019 - 04/2008
5	Obesity 03/2022 - 03/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2009
4	Neoplasms (Cancer) 01/2021 - 01/2019
3	Liver Diseases (Liver Disease) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2021 - 08/2014
3	Weight Gain 01/2021 - 11/2015
3	Insulin Resistance 04/2016 - 02/2013
3	Hypoglycemia (Reactive Hypoglycemia) 04/2016 - 08/2009
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 12/2021
2	Fatty Liver 01/2022 - 04/2014
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Muscle Weakness 01/2022 - 02/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2016
2	Hypertension (High Blood Pressure) 01/2021 - 11/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020 - 01/2012
2	Hypertrophy 01/2020 - 05/2016
2	Muscular Diseases (Myopathy) 01/2020 - 11/2015
2	Atherosclerosis 01/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 01/2016
2	Cognitive Dysfunction 01/2015 - 01/2015
2	Dyslipidemias (Dyslipidemia) 11/2013 - 01/2012
2	Hyperlipidemias (Hyperlipidemia) 09/2013 - 02/2013
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	Alcoholic Cardiomyopathy 01/2022
1	Pain (Aches) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Necrosis 01/2022
1	Femoral Fractures (Femoral Fracture) 01/2022
1	Blindness (Hysterical Blindness) 12/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021

Drug/Important Bio-Agent (IBA)

16	AcidsIBA 01/2022 - 08/2008
15	GlucosidasesIBA 01/2022 - 11/2010
6	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 11/2015
6	GlycogenIBA 01/2022 - 08/2008
6	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 04/2008
6	EnzymesIBA 12/2020 - 11/2010
5	LipidsIBA 07/2022 - 11/2013
5	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 12/2019 - 04/2008
5	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2019 - 11/2010
5	human GAA protein (Myozyme)FDA Link 05/2016 - 02/2010
4	Pharmaceutical PreparationsIBA 08/2022 - 10/2019
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2014
4	ClenbuterolIBA 05/2016 - 06/2011
3	Acetylcysteine (Siran)FDA LinkGeneric 06/2022 - 04/2014
3	CationsIBA 01/2019 - 01/2013
3	Insulin (Novolin)FDA Link 04/2016 - 11/2015
3	Nonesterified Fatty Acids (NEFA)IBA 08/2015 - 01/2012
3	Triglycerides (Triacylglycerol)IBA 08/2015 - 09/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022 - 12/2020
2	Retinaldehyde (Retinal)IBA 08/2022 - 12/2021
2	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2017
2	Biological ProductsIBA 01/2022 - 08/2015
2	Indicators and Reagents (Reagents)IBA 08/2021 - 02/2009
2	IronIBA 01/2021 - 02/2009
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2019
2	salvianolic acid AIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 01/2014
2	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 02/2016
2	Sirtuin 3IBA 01/2019 - 01/2017
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 05/2016
2	PalmitatesIBA 04/2017 - 11/2015
2	CholesterolIBA 04/2016 - 11/2013
2	stearic acid (magnesium stearate)FDA LinkGeneric 01/2016 - 02/2013
2	TeaIBA 01/2015 - 01/2015
2	AntibodiesIBA 01/2015 - 02/2010
2	AdiponectinIBA 08/2013 - 01/2013
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2013 - 11/2012
1	Streptozocin (Streptozotocin)FDA Link 08/2022
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 08/2022
1	Blood Glucose (Blood Sugar)IBA 08/2022
1	AlbuminsIBA 08/2022
1	Competitive Endogenous RNAIBA 06/2022
1	Messenger RNA (mRNA)IBA 06/2022
1	Long Noncoding RNAIBA 06/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2022
1	AntioxidantsIBA 03/2022
1	CeramidesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 01/2022
1	AndrogensIBA 01/2022
1	EndotoxinsIBA 01/2022
1	cimifuginIBA 01/2022
1	CoumarinsIBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2021
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 08/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 08/2021
1	Calcium Channels (Calcium Channel)IBA 08/2021
1	ferulic acid (sodium ferulate)IBA 01/2021

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2010
8	Enzyme Replacement Therapy 01/2020 - 02/2010
2	Lasers (Laser) 01/2020 - 10/2019
1	Phytotherapy (Herbal Therapy) 01/2022
1	Intramedullary Fracture Fixation 01/2022